WPW
CELG

Winthrop Partners - WNY’s Celgene Corp CELG Stock Holding History

Winthrop Partners - WNY’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100
Closed -$6.41K – 248
2018
Q4 		$6.41K Sell
100
-755
-88% -$55.7K 0.01% 217
2018
Q3 		$76.5K Hold
855
– – 0.06% 156
2018
Q2 		$67.9K Hold
855
– – 0.06% 167
2018
Q1 		$74.3K Buy
+855
New +$82.1K 0.06% 186

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winthrop Partners - WNY's CELG Position: Q1 2019 in Review

Winthrop Partners - WNY sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 100 shares — an estimated $6.41K sold.

Winthrop Partners - WNY first reported a position in CELG in Q1 2018 and held it in 4 quarters. The position peaked at $76.5K in Q3 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Winthrop Partners - WNY reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Winthrop Partners - WNY sold 100 Celgene Corp shares in Q1 2019, an estimated $6.41K.
  • Winthrop Partners - WNY first reported a position in Celgene Corp in Q1 2018 and held it in 4 quarters.
  • Winthrop Partners - WNY's Celgene Corp position peaked at $76.5K in Q3 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Winthrop Partners - WNY's 13F filing for Q1 2019, filed 15 May 2019.